Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging

Molecular Imaging and Biology

Volumn 13, Issue 5, 2011, Pages 995-1002

  De Saint Hubert, Marijke ^a   Wang, Huijun ^a   Devos, Ellen ^a   Vunckx, Kathleen ^a   Zhou, Lin ^a   Reutelingsperger, Chris ^c   Verbruggen, Alfons ^b   Mortelmans, Luc ^a   Ni, Yicheng ^a   Mottaghy, Felix M ^a,d,e  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F FDG and 99mTc hAnxA5; Chemotherapy response; Lymphoma; MRI

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; TECHNETIUM POLYHISTIDINE TAG ANNEXIN A5 TC 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; ISOTOPE LABELING; METABOLIC ACTIVATION; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MICE; MICE, SCID; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

MUS;

EID: 84855647263     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0412-z     Document Type: Article

References (34)

1. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
2. Juweid ME, Cheson BD (2006) Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354:496-507 (Pubitemid 43200300)
3. Spaepen K, Stroobants S, Dupont P et al (2002) Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 13:1356-1363
4. Brepoels L, Stroobants S, De WW et al (2007) Aggressive and indolent non-Hodgkin's lymphoma: Response assessment by integrated international workshop criteria. Leuk Lymphoma 48:1522-1530 (Pubitemid 47272802)
5. Zinzani PL, Stefoni V, Tani M et al (2009) Role of [18F] fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 27:1781-1787
6. Spaepen K, Stroobants S, Dupont P et al (2003) [(18)F]FDG PET monitoring of tumour response to chemotherapy: Does [(18)F]FDG uptake correlate with the viable tumour cell fraction? Eur J Nucl Med Mol Imaging 30:682-688 (Pubitemid 36612950)
7. Kubota R, Yamada S, Kubota K et al (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972-1980
8. Brepoels L, Stroobants S, Vandenberghe P et al (2007) Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy. J Nucl Med 48:390-397 (Pubitemid 47604924)
9. Joseph B, Lewensohn R, Zhivotovsky B (2000) Role of apoptosis in the response of lung carcinomas to anti-cancer treatment. Ann NY Acad Sci 926:204-216 (Pubitemid 32050157)
10. Fromigue O, Lagneaux L, Body JJ (2000) Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 15:2211-2221
11. Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W (2000) Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Gynecol Oncol 79:169-176
12. Neves AA, Brindle KM (2006) Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta 1766:242-261
13. De Saint-Hubert M, Prinsen K, Mortelmans L, Verbruggen A, Mottaghy FM (2009) Molecular imaging of cell death. Methods 48:178-187
14. Hofstra L, Liem IH, Dumont EA et al (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356:209-212 (Pubitemid 30446976)
15. Belhocine T, Steinmetz N, Hustinx R et al (2002) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8:2766-2774 (Pubitemid 35025718)
16. Belhocine T, Steinmetz N, Li C, Green A, Blankenberg FG (2004) The imaging of apoptosis with the radiolabeled annexin V: Optimal timing for clinical feasibility. Technol Cancer Res Treat 3:23-32 (Pubitemid 38250465)
17. Rottey S, Loose D, Vakaet L et al (2007) 99mTc-HYNIC annexin-V imaging of tumors and its relationship to response to radiotherapy and/ or chemotherapy. Q J Nucl Med Mol Imaging 51:182-188 (Pubitemid 47064658)
18. Rottey S, Slegers G, Van BS, Goethals I, Van de WC (2006) Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med 47:1813-1818 (Pubitemid 47545004)
19. Kartachova M, van ZN, Burgers S et al (2007) Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol 25:2534-2539 (Pubitemid 47041226)
20. De Saint-Hubert M, Mottaghy FM, Vunckx K et al (2010) Site-specific labeling of 'second generation' annexin V with (99m)Tc(CO)(3) for improved imaging of apoptosis in vivo. BioorgMed Chem 18(3):1356-1363
21. Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530 (Pubitemid 13160576)
22. Ghetie MA, Richardson J, Tucker T et al (1990) Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int J Cancer 45:481-485 (Pubitemid 20087196)
23. Corbett TH, Griswold DP, Mayo JG, Laster WR, Schabel FM Jr (1975) Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Cancer Res 35:1568-1573
24. Larson SM, Erdi Y, Akhurst T et al (1999) Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 2:159-171
25. Willner J, Baier K, Pfreundner L, Flentje M (1999) Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncol 38:1025-1030 (Pubitemid 30033024)
26. Vunckx K, Beque D, Defrise M, Nuyts J (2008) Single and multipinhole collimator design evaluation method for small animal SPECT. IEEE Trans Med Imaging 27:36-46
27. Ghetie MA, Tucker K, Richardson J, Uhr JW, Vitetta ES (1994) Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail. Blood 84:702-707 (Pubitemid 24223863)
28. Cooper IA, Wolf MM, Robertson TI et al (1994) Randomized comparison of MACOP-B with CHOP in patients with intermediategrade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group. J Clin Oncol 12:769-778
29. Itoh K, Ohtsu T, Sasaki Y et al (2000) Randomized comparison of mobilization kinetics of circulating CD34+ cells between biweekly CHOP and dose-escalated CHOP with the prophylactic use of lenograstim (glycosylated rHuG-CSF) in aggressive non-Hodgkin's lymphoma. The Lenograstim/Lymphoma Study Group. Leuk Lymphoma 38:521-532 (Pubitemid 30614537)
30. Aide N, Poulain L, Briand M et al (2009) Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: Early flare response does not reflect refractory disease. Eur J Nucl Med Mol Imaging 36:396-405
31. Mandl SJ, Mari C, Edinger M et al (2004) Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging 3:1-8
32. Sterin-Speziale N, Kahane VL, Setton CP, Fernandez MC, Speziale EH (1992) Compartmental study of rat renal phospholipid metabolism. Lipids 27:10-14
33. Verheij M (2008) Clinical biomarkers and imaging for radiotherapyinduced cell death. Cancer Metastasis Rev 27:471-480
34. Brepoels L, De Saint-Hubert M, Stroobants S et al (2010) Dose- response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [(18)F]FDG PET. Eur J Nucl Med Mol Imaging 37(9):1688-1695